Literature DB >> 12395379

Composite germ cell tumor and B-cell non-Hodgkin's lymphoma arising in the sella turcica.

Riccardo Valdez1, Paul McKeever, William G Finn, Stephen Gebarski, Bertram Schnitzer.   

Abstract

We report the case of a composite malignant neoplasm consisting of germ cell tumor and B-cell non-Hodgkin's lymphoma occurring in the sella turcica of a young girl who presented with hypopituitarism. Routine hematoxylin and eosin-stained sections of a resected suprasellar tumor demonstrated a neoplasm composed of 2 distinct morphologies. A panel of immunohistochemical markers was used to confirm the morphologic impression of germinoma (cytokeratin AE1/AE3-CAM 5.2, cytokeratin 7, neuron-specific enolase, and focally placental alkaline phosphatase positive) and mature B-cell lymphoma (CD20 positive; pancytokeratin, placental alkaline phosphatase, and terminal deoxynucleotidyl transferase negative). To the best of our knowledge, this is the first reported case of such a composite tumor in the central nervous system. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395379     DOI: 10.1053/hupa.2002.128063

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Pituitary stalk thickening and primary central nervous system lymphoma.

Authors:  M Capra; D Wherrett; S Weitzman; P Dirks; C Hawkins; E Bouffet
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

2.  Primary pituitary lymphoma: a histological, immunohistochemical, and ultrastructural study with literature review.

Authors:  Olga Moshkin; Paul Muller; Bernd W Scheithauer; Jonathan Juco; Eva Horvath; Bruce J Patterson; Suzzane Kamel-Reid; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

Review 3.  Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM).

Authors:  Peter Arend
Journal:  Cancer Med       Date:  2017-06-05       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.